Skip to main content

Advertisement

Table 3 The outcome indicatorsa, b

From: A cluster randomized trial to assess the effect of clinical pathways for patients with stroke: results of the clinical pathways for effective and appropriate care study

Variables Clinical pathway, n = 238 No intervention, n = 238 Between-group difference, OR (95% CI) P-valuec
In-hospital death rate within 30 days of admission to hospital 18/238 (7.6) (4.5 to 11.7) 25/238 (10.5) (6.9 to 15.1) 0.70 (0.35 to 1.37) 0.34
In-hospital death rate within 7 days of admission to hospital 7/238 (2.9) (1.2 to 6.0) 16/238 (6.7) (3.6 to 10.2) 0.42 (0.15 to 1.11) 0.05
In-hospital death rate within 30 days of stroke attack 18/238 (7.6) (4.5 to 11.7) 25/238 (10.5) (6.9 to 15.1) 0.70 (0.35 to 1.37) 0.34
Post-discharge death rates (1, 3, 6, 12 months after discharge) 3/53 (5.7) (1.2 to 15.7) 0/27 (0.0) (0.0 to 12.8) 1.54 (1.31 to 1.81) 0.55
In-patients length of stay, n (mean ± SD) 229 (11.78 ± 6.6) 219 (10.88 ± 7.9) - 0.19
Within 9 days of length of stay in hospital patients' rate 94/227 (41.4) (34.9 to 48.1) 114/215 (53.0) (46.1 to 59.8) 1.60 (1.08 to 2.37) 0.02
Pressure-sore incidence rate 4/229 (1.7) (0.5 to 4.4) 12/219 (5.5) (2.9 to 9.4) 0.31 (0.08 to 0.94) 0.04
Overall in-hospital complications rate 53/229 (23.1) (17.8 to 29.2) 67/219 (30.6) (24.6 to 37.2) 0.68 (0.44 to 1.06) 0.09
Overall post-discharge complications rate 12/103 (11.7) (6.2 to 19.5) 0/27 (0.0) (0.0 to 12.8) 1.30 (0.98 to 1.43) 0.07
Institutionalization at discharge 26/92 (28.3) (19.4 to 38.6) 15/64 (23.4) (14.0 to 36.2) 1.29 (0.58 to 2.87) 0.58
In-hospital re-admission rate (within 30 days of discharge) 0/211 (0.0) (NC) 0/194 (0.0) (NC) NC NC
Return to pre-stroke functioning in daily life rate (with ADL/case mix adjustment) 97/208 (46.6) (39.1 to 52.9) 22/90 (24.4) (16.0 to 34.6) 2.70 (1.50 to 4.88) < 0.001
Return to pre-stroke functioning in daily life rate at follow-up at 3 months (with ADL/case mix adjustment) 62/101 (61.4) (51.2 to 70.9) 5/9 (55.5) (21.2 to 86.3) 1.27 (0.27 to 5.92) 0.73
  1. ADL, Activities of daily living; NC, Not calculable
  2. aBecause of missing data denominators used to calculate percentages may differ from group totals (clinical pathway versus no intervention).
  3. bValues are n/total n (%) (95% CI) unless otherwise indicated.
  4. c P-values represent comparison of each characteristic between two groups (clinical pathway versus no intervention), and all P-values are two-sided.